glp 1 for longevity Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a group of drugs now routinely prescribed type 2 diabetes and obesity, are being sought out by healthy people in the hope that they will Noom Launches GLP-1 Microdosing for

40% of police officers and firefighters have obesity and 80% are overweight

Meal frequency and timing matter more than total calories during semaglutide use

Incretin-based therapies work either by preventing enzymatic degradation of GLP-1, thus maintaining plasma levels of endogenous GLP-1 (dipeptidyl peptidase 4 inhibitors, DPP4is) or by directly activating GLP-1 receptors and mimicking the action of native GLP-1 (glucagon-like peptide-1 receptor agonists, GLP-1 RAs) [9]

GLP-1 and GLP-1/GIP polypeptide therapy can be an effective adjunct in addressing the obesity epidemic

GLP-1 oral liquid dosing frequency works best when the timing is consistent to within about an hour each day